As per MRFR analysis, the India Neuropsychiatric Disorders Treatment Market Size was estimated at 6.58 (USD Billion) in 2023. The India Neuropsychiatric Disorders Treatment Market Industry is expected to grow from 7.25(USD Billion) in 2024 to 23.75 (USD Billion) by 2035. The India Neuropsychiatric Disorders Treatment Market CAGR (growth rate) is expected to be around 11.39% during the forecast period (2025 - 2035)
Key India Neuropsychiatric Disorders Treatment Market Trends Highlighted
The India Neuropsychiatric Disorders Treatment Market is experiencing significant growth driven by the increasing prevalence of mental health disorders among the Indian population. Growing awareness regarding mental health issues and the need for effective treatment is leading to higher demand for various therapies and medications. Government initiatives, such as the National Mental Health Programme, have also focused on improving mental health services, which serves as a crucial market driver. Additionally, the stigma surrounding neuropsychiatric disorders is gradually diminishing, enabling more individuals to seek help and thereby increasing treatment uptake.
Teletherapy and mobile healthcare apps are two modern approaches to treatment that have embraced technology. This trend is especially meaningful to India because people in rural areas lack access to traditional healthcare facilities. These advancements provide new ways of treatment that address many needs as well as make it easier to reach a greater audience. Additionally, the growing investment in R&D to find new drugs and treatment methods demonstrates an interest in developing personalized treatment plans.
There is also a change in focus towards developing mental health literacy programs for the general population aimed at the early diagnosis of neuropsychiatric disorders and the timely provision of needed care. The combination of these factors creates opportunities for the country's stakeholders to respond to the need for greater mental health services and resources, which can be effectively tapped. India has made significant changes to its mental healthcare infrastructureand is now capable of providing comprehensive care.
India Neuropsychiatric Disorders Treatment Market Drivers
Rising Incidence of Mental Health Disorders
The prevalence of mental health disorders in India has reached alarming levels, with estimates suggesting that nearly 14% of the population suffers from various neuropsychiatric conditions such as depression, anxiety, and schizophrenia. This figure translates to over 150 million individuals requiring treatment. The National Mental Health Survey by the Government of India indicates a significant rise in cases over the past decade, with mental health conditions projected to contribute substantially to the overall disease burden in the country.With organizations like the Indian Psychiatric Society advocating for increased awareness and treatment accessibility, the India Neuropsychiatric Disorders Treatment Market Industry is poised for notable growth as more individuals seek medical help.
Government Initiatives and Policy Support
The Indian government has been proactive in addressing mental health issues through various initiatives and policy frameworks. The launch of the 'Mental Healthcare Act' in 2017 aims to provide comprehensive mental health services and ensure patients' rights. Additionally, the National Health Mission encourages the integration of mental health services into primary healthcare. These initiatives have led to an improved understanding of neuropsychiatric disorders and increased funding for treatment facilities.The engagement of healthcare organizations and NGOs such as the Vandrevala Foundation has further enhanced the capacity for research and treatment options, amplifying the growth potential of the India Neuropsychiatric Disorders Treatment Market Industry.
Growing Awareness and Reduced Stigma
There is a significant shift in societal attitudes towards mental health in India, thanks to comprehensive awareness campaigns led by various organizations. Initiatives by the World Health Organization and local NGOs have played a pivotal role in educating the public about neuropsychiatric disorders. Public figures and celebrities openly discussing their mental health struggles have further contributed to reducing stigma. As awareness increases, more individuals are willing to seek help, resulting in a rising demand for treatment options.The India Neuropsychiatric Disorders Treatment Market Industry stands to benefit as a wider segment of the population seeks institutional and therapeutic interventions for their mental health needs.
India Neuropsychiatric Disorders Treatment Market Segment Insights
Neuropsychiatric Disorders Treatment Market Type Insights
The India Neuropsychiatric Disorders Treatment Market is diverse and can be categorized into several key types that play significant roles in addressing various conditions impacting mental health. Among these types, Degenerative Diseases are gaining attention due to their long-term effects and increasing prevalence within the Indian population, particularly among older adults who face cognitive decline and other debilitating symptoms. Neurotic Disorders, encompassing anxiety and mood-related issues, have seen a rise in awareness and diagnosis, fueled by changing societal attitudes towards mental health, thus creating a substantial demand for effective treatments.Psychosis remains a crucial focus area as it presents severe challenges for both patients and their families, making comprehensive treatment approaches vital.
Additionally, the "Others" category encompasses various lesser-known conditions that still significantly burden the healthcare system, highlighting the need for innovative treatment solutions and awareness in the community. The India Neuropsychiatric Disorders Treatment Market segmentation not only showcases the diverse conditions but also underscores the evolving understanding of mental health in India, where cultural stigmas are slowly being replaced by a drive for better healthcare access and support.As the country's healthcare system continues to adapt, there exist ample opportunities for growth in treatment modalities across all these types, ensuring that various subsets of the population receive the necessary care for their unique challenges. Rising healthcare expenditure and government initiatives targeting mental health policies are likely to propel further investment in this market segment, which is reflective of a broader trend towards prioritizing mental health as an integral part of holistic healthcare in India.
Neuropsychiatric Disorders Treatment Market Application Insights
The Application segment within the India Neuropsychiatric Disorders Treatment Market is pivotal in addressing the diverse needs of patients suffering from various neuropsychiatric conditions. This segment includes techniques like Shock Treatment, which is noteworthy for its historical significance and continued use in treatment protocols for severe depression and other disorders, proving to be a crucial tool in psychiatric care. Drug Treatment remains a cornerstone in this segment, reflecting the growing reliance on pharmaceuticals to manage symptoms effectively.As the prevalence of neuropsychiatric disorders rises, the demand for innovative drug therapies expands, highlighting the need for ongoing research and development in this field. Other methods complement these primary approaches, providing additional avenues for treatment and emphasizing the market's extensive nature.
Overall, the dynamics of the India Neuropsychiatric Disorders Treatment Market segmentation indicate a rapidly evolving landscape driven by both patient needs and advancements in medical science, making the Application segment integral for enhancing therapeutic outcomes.The current landscape showcases the necessity of tailored treatment plans for the diverse patient population, ensuring that every individual receives the most effective care based on their unique conditions.
Neuropsychiatric Disorders Treatment Market End User Insights
The End User segment of the India Neuropsychiatric Disorders Treatment Market is characterized by its diverse categories, which include Hospitals, Clinics, Research Centres, and others. Hospitals play a crucial role in providing comprehensive care for patients with neuropsychiatric disorders, addressing a wide range of conditions such as depression, anxiety, and more severe psychiatric illnesses. Clinics, on the other hand, typically offer specialized outpatient services, focusing on preventative care and early intervention, greatly enhancing patient accessibility to treatment.Research Centres contribute significantly to the landscape by facilitating innovative treatments and clinical trials, which is important for advancing knowledge in neuropsychiatric conditions in India.
The growing awareness and destigmatization surrounding mental health is driving demand across these sectors, while an increase in healthcare funding and government initiatives further support market growth. Additionally, the infrastructure growth in urban areas provides opportunities to expand services while challenges such as the need for trained professionals and patient follow-up protocols persist.Overall, the segmentation reveals a complex interplay of healthcare facilities tailored to address the unique needs of those suffering from neuropsychiatric disorders across India.
India Neuropsychiatric Disorders Treatment Market Key Players and Competitive Insights
The India Neuropsychiatric Disorders Treatment Market has observed significant growth in recent years, fueled by an increasing prevalence of various mental health disorders and a growing awareness of mental health issues among the general population. This market is characterized by a dynamic competitive landscape, with numerous key players striving to establish their presence through innovative treatment options, robust marketing strategies, and partnerships with healthcare institutions. Given the rising demand for effective neuropsychiatric therapies, companies are investing substantially in research and development to introduce new treatment modalities and improve existing ones.
Furthermore, the regulatory environment in India is evolving, prompting companies to adapt their approaches to meet compliance standards while catering to the specific needs of Indian patients.GSK India holds a prominent position in the India Neuropsychiatric Disorders Treatment Market, leveraging its extensive experience and established presence in the pharmaceutical sector. The company is recognized for its strong portfolio of neuropsychiatric medications that address a wide range of conditions, including depression, anxiety disorders, and schizophrenia. GSK India's strengths lie in its commitment to research and its ability to bring innovative medications to the market. With a well-structured distribution network and strong partnerships with healthcare professionals, GSK India has been successful in penetrating a wide audience.
The company's focus on enhancing patient access to treatments, coupled with its robust clinical trials, contributes significantly to its competitive edge in the neuropsychiatric treatment arena.Sawai Pharmaceuticals has made considerable strides in the India Neuropsychiatric Disorders Treatment Market, primarily by focusing on innovative therapies and expanding its product offerings. The company emphasizes the development of key products that cater to various mental health challenges, ensuring they meet the local population's needs. Sawai Pharmaceuticals benefits from strong research capabilities and a proactive approach to mergers and acquisitions, which has bolstered its market presence and diversified its treatment portfolio.
By collaborating with local healthcare providers and investing in education programs aimed at reducing stigma around neuropsychiatric disorders, Sawai Pharmaceuticals strengthens its brand reputation in India. Its ongoing commitment to understanding patient needs and expanding access to effective treatments further solidifies its position in a competitive market environment.
Key Companies in the India Neuropsychiatric Disorders Treatment Market Include
India Neuropsychiatric Disorders Treatment Market Industry Developments
The India Neuropsychiatric Disorders Treatment Market is witnessing significant developments, particularly in the pharmaceutical sector. Companies such as Sun Pharmaceutical Industries and Cipla have recently expanded their product portfolios to include innovative psychiatric treatments, aiming to address the rising demand caused by increasing awareness and prevalence of mental health issues. Notably, in August 2023, Wockhardt announced a strategic partnership to enhance drug delivery mechanisms for neuropsychiatric medications, showcasing the focus on research and development in this sector. Additionally, in May 2022, Zydus Cadila launched a new formulation targeting depression and anxiety disorders, reflecting the growing emphasis on mental health treatments in India.
Mergers and acquisitions have also marked the landscape; in September 2023, Piramal Enterprises acquired a specialty pharmaceutical unit from Abbott, India, which could potentially enhance its neuropsychiatric offerings. The growth in the market valuation of companies like Dr. Reddy's Laboratories and Intas Pharmaceuticals is indicative of the sector's vitality, with significant investments being funneled into R&D. The increasing recognition of mental health issues is likely to continue influencing the competitive dynamics among leading players such as GSK India, Torrent Pharmaceuticals, and Aurobindo Pharma, shaping the future of neuropsychiatric treatment in India.
India Neuropsychiatric Disorders Treatment Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 6.58(USD Billion) |
| MARKET SIZE 2024 | 7.25(USD Billion) |
| MARKET SIZE 2035 | 23.75(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.39% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | GSK India, Sawai Pharmaceuticals, Zydus Cadila, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Piramal Enterprises, Intas Pharmaceuticals, Abbott India, Mylan Laboratories, Cipla, Aurobindo Pharma, Lupin, Wockhardt, Dr. Reddy's Laboratories, Alkem Laboratories |
| SEGMENTS COVERED | Type, Application, End User |
| KEY MARKET OPPORTUNITIES | Growing mental health awareness, Increased telemedicine adoption, Expanding healthcare infrastructure, Rising investment in research, Demand for personalized treatment options |
| KEY MARKET DYNAMICS | rising prevalence of disorders, increasing healthcare expenditure, growing awareness and acceptance, innovation in treatment approaches, strong government initiatives |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Neuropsychiatric Disorders Treatment Market is projected to be valued at 7.25 billion USD in 2024.
By 2035, the market value is expected to reach 23.75 billion USD.
The expected CAGR for the market from 2025 to 2035 is 11.39 percent.
In 2024, the Neurotic Disorders segment has the highest valuation at 2.5 billion USD.
The Psychosis segment is expected to be valued at 5.5 billion USD in 2035.
Key players in the market include GSK India, Sun Pharmaceutical Industries, Zydus Cadila, and others.
The market for Degenerative Diseases is projected to be valued at 8.0 billion USD in 2035.
Growth opportunities are driven by increasing awareness and improved treatment options.
Challenges include high treatment costs and a shortage of qualified mental health professionals.
Current trends, including technological advancements, are positively impacting market growth and treatment options.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
